All publications
Impact of Granulation Solvent on Release Performance of Dual Matrix Extended-Release Tablets of Highly Water Soluble Drugs Formulated using Compritol® 888 ATO and Methocel® as Release Retarding Agents
AAPS PharmSci360 – Boston (USA) - Oct 2022
The purpose of this study is to evaluate the impact of different granulation solvents on the performance of dual extended- release matrix tablets, formulated using a combination of Compritol® 888 ATO and Methocel® K100M, with two model APIs:
- highly water-soluble high dose (1000 mg) Metformin Hydrochloride
- freely water-soluble low dose (95 mg) Metoprolol Succinate
A Systematic Approach to Developing Lipid-Based Drug Delivery Systems with Fenofibrate as Model Drug
AAPS PharmSci360 – Boston (USA) - Oct 2022
Formulation et fabrication des suppositoires [Formulation and manufacturing of suppositories].
Techniques de l’Ingénieur - Oct 2022
Formulation et fabrication des suppositoires [Formulation and manufacturing of suppositories].
Techniques de l’Ingénieur - Oct 2022
Effect of Lipid Vehicles on Solubility, Stability, and Topical Permeation of Delta 9 Tetrahydrocannabinol
AAPS PharmSciTech, 23:223 - Jul 2022
Labrafac™ MC60 acts as an intestinal permeation enhancer in isolated rat colonic and jejunal mucosae in the Ussing chambers
CRS Annual Meeting – Montreal (Canada) - Jul 2022
Gelucire® 48/16: a safe wetting agent for tablet. A case study with fenofibrate
CRS Annual Meeting – Montreal (Canada) - Jul 2022
Importance of standardizing protocols for pig skin preparation to ensure reliable in vitro permeation test (IVPT) results
CRS Annual Meeting – Montreal (Canada) - Jul 2022
Effect of Select Enhancers on the Permeation of Caffeine Across Strat® M Membrane
CRS Annual Meeting – Montreal (Canada) - Jul 2022